GlaxoSmithKline plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Sir Jonathan Symonds, was filed 24 Jun 2022.
GlaxoSmithKline plc: what insiders have been doing
GlaxoSmithKline plc is a listed company. Its directors and officers file their transactions with RNS (LSE). GlaxoSmithKline plc has had no insider filing for more than a year; the last one goes back to 12 July 2022.
Since 2013, the database holds 250 purchases and 78 sales by insiders of the company.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 1,189.015 shares@ US$43.320.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4436954
- 1,455.157 shares@ US$43.39360.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4434509-0
- 282.957 shares@ US$43.39360.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4434509-1
- 931.159 shares@ US$43.39360.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4434509-2
- 50.58 shares@ US$43.393635.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4434509-3
- 18 shares@ £18.09940.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434471
- 3,359.761 shares@ £17.90940.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-6
- 801.588 shares@ £17.90940.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-7
- 866.882 shares@ £17.90940.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-8
- 4,208.88 shares@ £17.90940.5% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-5
- 2,049.656 shares@ £17.90940.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-0
- 2,294.439 shares@ £17.90940.5% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-1
- 5.658 shares@ £17.90920.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-2
- 232.599 shares@ £17.90940.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-3
- 124.792 shares@ £17.90940.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-4
- 96.112 shares@ £17.90946.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-9
- 226.93 shares@ £17.90940.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-10
- 7,436.779 shares@ £17.8560.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434317-0
- 1,213.975 shares@ £17.8560.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434317-1
- 1,421 shares@ £17.8560.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434280-0
- 432 shares@ £17.8560.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434280-8
- 974 shares@ £17.8560.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434280-1
- 774 shares@ US$43.750.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:4434280-2
- 326 shares@ £17.8560.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434280-3
- 205 shares@ £17.8560.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434280-4
25 of 2973 declarations
About GlaxoSmithKline plc
GlaxoSmithKline plc is a British pharmaceutical company focused on the research, development, and marketing of medicines, vaccines, and consumer health products. It is listed on the London Stock Exchange under the ticker GSK.
